Results 31 to 40 of about 21,501 (259)
Fixed drug eruption resulting from fluconazole use: a case report
Journal of Medical Case Reports, 2009 Introduction Fluconazole is a widely used antifungal agent with a possible side effect of fixed drug eruption. However, this adverse drug effect is absent from the reported list of possible side effects of fluconazole.
Tavallaee Mahkam, Rad Mahnaz Mahmoudi
doaj +1 more source
Dermatology Online Journal, 2009 A 78-year-old man presented with an eight-month history of folliculocentric, pink, hyperkeratotic papules and plaques with thick white scale that involved the entire body, with confluence on the buttocks and genitalia. A biopsy specimen demonstrated superficial and focal, mild perivascular and perifollicular, band-like lymphocytic infiltrate and ...
Brauer, Jeremy +3 more
openaire +4 more sources
Evaluating a virtual paediatric adverse drug reaction clinic
British Journal of Clinical Pharmacology, EarlyView.Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck +2 more
wiley +1 more source
Case Reports in Dermatology, 2020 Mycoplasma infection may lower the threshold for drug allergy in particular patients. We present a case of drug reaction with eosinophilia and systemic symptoms (DRESS), with drug etiology and non-drug etiology (Mycoplasma infection).
Guy Shalom, Raed Khoury, Amir Horev
doaj +1 more source
Clinical Advances in Periodontics, EarlyView.Abstract Background The aim of the study is to report clinical outcomes of autogenous tooth transplantation (ATT) of fully developed third molars following the extraction of periodontally hopeless teeth as a part of the treatment of a stage III, grade C, molar‐incisor pattern (MIP) periodontitis case.
Alessandro Rizzi +3 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.BRAF inhibitors and MEK inhibitors (MEKi) have reshaped the treatment of BRAFV600‐mutant malignancies; however, cutaneous adverse drug reactions (ADRs) remain a frequent and clinically impactful toxicity. Although clinical trials provide insight into their safety profiles, real‐world data on dermatologic ADRs are limited.
Natalia Sauer +3 more
wiley +1 more source
Dermatology Research and Practice, 2015 Background. Generalized fixed drug eruption is a specific variant of fixed drug eruption with multifocal lesions. Diagnosis of this drug reaction is straightforward, but occasionally recognition of the causative drug is not possible. This study was aimed
Hossein Kavoussi +6 more
doaj +1 more source
A Probable Case of Mucosal Fixed Drug Eruption Following Treatment with Silodosin
Sultan Qaboos University Medical Journal, 2018 A fixed drug eruption consists of erythematous patches that appear on the skin and/or mucous membranes following administration of a drug which, once healed, leaves residual hyperpigmentation.
Eleni Klimi
doaj +1 more source
Ixekizumab‐induced urticarial drug eruption
Skin Health and Disease, 2023 Biological agents targeting inflammatory skin diseases have dramatically overcome many of the limitations of older oral therapeutic options. Among the various biological agents, ixekizumab is a humanised monoclonal antibody that blocks the biological ...
Ayaka Kaneoka +3 more
doaj +1 more source
Multifocal Bullous Fixed Drug Eruption
Acta Médica Portuguesa, 2022 N/a.
Carolina Oliveira +2 more
doaj +1 more source